vs

Side-by-side financial comparison of INDEPENDENT BANK CORP (INDB) and NEOGENOMICS INC (NEO). Click either name above to swap in a different company.

INDEPENDENT BANK CORP is the larger business by last-quarter revenue ($212.5M vs $186.7M, roughly 1.1× NEOGENOMICS INC). INDEPENDENT BANK CORP runs the higher net margin — 35.5% vs -57.9%, a 93.3% gap on every dollar of revenue. On growth, INDEPENDENT BANK CORP posted the faster year-over-year revenue change (46.9% vs 11.1%). Over the past eight quarters, INDEPENDENT BANK CORP's revenue compounded faster (24.3% CAGR vs 6.5%).

Independent Bank is a bank headquartered in Grand Rapids, Michigan. The bank has 62 branches, all of which are in Michigan.

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

INDB vs NEO — Head-to-Head

Bigger by revenue
INDB
INDB
1.1× larger
INDB
$212.5M
$186.7M
NEO
Growing faster (revenue YoY)
INDB
INDB
+35.8% gap
INDB
46.9%
11.1%
NEO
Higher net margin
INDB
INDB
93.3% more per $
INDB
35.5%
-57.9%
NEO
Faster 2-yr revenue CAGR
INDB
INDB
Annualised
INDB
24.3%
6.5%
NEO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
INDB
INDB
NEO
NEO
Revenue
$212.5M
$186.7M
Net Profit
$75.3M
$-108.0M
Gross Margin
43.3%
Operating Margin
46.9%
Net Margin
35.5%
-57.9%
Revenue YoY
46.9%
11.1%
Net Profit YoY
50.6%
42.0%
EPS (diluted)
$1.51
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INDB
INDB
NEO
NEO
Q1 26
$186.7M
Q4 25
$212.5M
$190.2M
Q3 25
$203.3M
$187.8M
Q2 25
$147.5M
$181.3M
Q1 25
$145.5M
$168.0M
Q4 24
$144.7M
$172.0M
Q3 24
$141.7M
$167.8M
Q2 24
$137.9M
$164.5M
Net Profit
INDB
INDB
NEO
NEO
Q1 26
$-108.0M
Q4 25
$75.3M
Q3 25
$34.3M
$-27.1M
Q2 25
$51.1M
$-45.1M
Q1 25
$44.4M
$-25.9M
Q4 24
$50.0M
Q3 24
$42.9M
$-17.7M
Q2 24
$51.3M
$-18.6M
Gross Margin
INDB
INDB
NEO
NEO
Q1 26
43.3%
Q4 25
43.8%
Q3 25
42.8%
Q2 25
42.6%
Q1 25
43.6%
Q4 24
44.9%
Q3 24
44.6%
Q2 24
44.1%
Operating Margin
INDB
INDB
NEO
NEO
Q1 26
46.9%
Q4 25
-7.1%
Q3 25
21.8%
-14.4%
Q2 25
44.6%
-26.3%
Q1 25
39.3%
-16.6%
Q4 24
-10.7%
Q3 24
39.0%
-12.6%
Q2 24
48.1%
-13.3%
Net Margin
INDB
INDB
NEO
NEO
Q1 26
-57.9%
Q4 25
35.5%
Q3 25
16.8%
-14.4%
Q2 25
34.6%
-24.9%
Q1 25
30.5%
-15.4%
Q4 24
34.6%
Q3 24
30.3%
-10.5%
Q2 24
37.2%
-11.3%
EPS (diluted)
INDB
INDB
NEO
NEO
Q1 26
$-0.13
Q4 25
$1.51
Q3 25
$0.69
Q2 25
$1.20
Q1 25
$1.04
Q4 24
$1.18
Q3 24
$1.01
Q2 24
$1.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INDB
INDB
NEO
NEO
Cash + ST InvestmentsLiquidity on hand
$146.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$3.6B
$828.8M
Total Assets
$24.9B
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INDB
INDB
NEO
NEO
Q1 26
$146.1M
Q4 25
$159.6M
Q3 25
$164.1M
Q2 25
$154.7M
Q1 25
$346.2M
Q4 24
$367.0M
Q3 24
$362.0M
Q2 24
$355.1M
Total Debt
INDB
INDB
NEO
NEO
Q1 26
Q4 25
$341.9M
Q3 25
Q2 25
Q1 25
Q4 24
$541.1M
Q3 24
Q2 24
Stockholders' Equity
INDB
INDB
NEO
NEO
Q1 26
$828.8M
Q4 25
$3.6B
$836.6M
Q3 25
$3.5B
$838.3M
Q2 25
$3.1B
$854.0M
Q1 25
$3.0B
$888.3M
Q4 24
$3.0B
$902.3M
Q3 24
$3.0B
$908.2M
Q2 24
$2.9B
$915.9M
Total Assets
INDB
INDB
NEO
NEO
Q1 26
$1.3B
Q4 25
$24.9B
$1.4B
Q3 25
$25.0B
$1.4B
Q2 25
$20.0B
$1.4B
Q1 25
$19.9B
$1.6B
Q4 24
$19.4B
$1.6B
Q3 24
$19.4B
$1.6B
Q2 24
$19.4B
$1.6B
Debt / Equity
INDB
INDB
NEO
NEO
Q1 26
Q4 25
0.41×
Q3 25
Q2 25
Q1 25
Q4 24
0.60×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INDB
INDB
NEO
NEO
Operating Cash FlowLast quarter
$78.9M
$-8.1M
Free Cash FlowOCF − Capex
$75.5M
FCF MarginFCF / Revenue
35.5%
Capex IntensityCapex / Revenue
1.6%
Cash ConversionOCF / Net Profit
1.05×
TTM Free Cash FlowTrailing 4 quarters
$239.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INDB
INDB
NEO
NEO
Q1 26
$-8.1M
Q4 25
$78.9M
$1.3M
Q3 25
$52.2M
$8.9M
Q2 25
$106.7M
$20.3M
Q1 25
$13.3M
$-25.3M
Q4 24
$42.9M
$9.8M
Q3 24
$70.2M
$9.2M
Q2 24
$65.6M
$13.9M
Free Cash Flow
INDB
INDB
NEO
NEO
Q1 26
Q4 25
$75.5M
$-6.5M
Q3 25
$49.7M
$570.0K
Q2 25
$102.5M
$14.0M
Q1 25
$11.3M
$-29.8M
Q4 24
$36.5M
$-1.8M
Q3 24
$64.4M
$-1.6M
Q2 24
$61.9M
$814.0K
FCF Margin
INDB
INDB
NEO
NEO
Q1 26
Q4 25
35.5%
-3.4%
Q3 25
24.4%
0.3%
Q2 25
69.5%
7.7%
Q1 25
7.8%
-17.8%
Q4 24
25.2%
-1.0%
Q3 24
45.4%
-0.9%
Q2 24
44.9%
0.5%
Capex Intensity
INDB
INDB
NEO
NEO
Q1 26
Q4 25
1.6%
4.1%
Q3 25
1.2%
4.4%
Q2 25
2.9%
3.5%
Q1 25
1.4%
2.7%
Q4 24
4.4%
6.7%
Q3 24
4.1%
6.4%
Q2 24
2.7%
8.0%
Cash Conversion
INDB
INDB
NEO
NEO
Q1 26
Q4 25
1.05×
Q3 25
1.52×
Q2 25
2.09×
Q1 25
0.30×
Q4 24
0.86×
Q3 24
1.64×
Q2 24
1.28×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons